CAR T therapy leads to full remission in chemotherapy-resistant liver tumor
A report in The New England Journal of Medicine documents a case where hepatoblastoma in a 3-year-old boy completely regressed after two doses of CAR-T cell treatment. This represents the first documented instance of a durable complete response in a chemotherapy-resistant solid tumor.
- Field
- gene therapy
- What they did
- Researchers documented a case where a three-year-old boy with liver cancer (hepatoblastoma) achieved complete regression of the tumor after two doses of CAR T cell therapy.
- Why it matters
- This could be useful because CAR T cell therapy had previously been limited to treating blood cancers, and this case demonstrates its potential effectiveness against solid tumors.
#car-t cell therapy#hepatoblastoma#solid tumor#clinical trial#immunotherapy



